UCB SA (EBR: UCB)
Belgium
· Delayed Price · Currency is EUR
188.20
-1.15 (-0.61%)
Jan 31, 2025, 5:35 PM CET
UCB SA Employees
As of December 31, 2023, UCB SA had 9,083 total employees, including 8,450 full-time and 633 part-time employees. The number of employees increased by 380 or 4.37% compared to the previous year.
Employees
9,083
Change (1Y)
380
Growth (1Y)
4.37%
Revenue / Employee
€606,000
Profits / Employee
€26,667
Market Cap
35.71B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
argenx SE | 1,148 |
Fagron NV | 3,282 |
Ion Beam Applications | 2,145 |
Nyxoah | 147 |
Onward Medical | 99 |
Hyloris Pharmaceuticals | 41 |
Sequana Medical NV | 62 |
Celyad Oncology | 19 |
UCB SA News
- 10 days ago - United Community Banks, Inc. (UCB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 10 days ago - United Community Banks Non-GAAP EPS of $0.63 beats by $0.07, revenue of $239.47M misses by $3.26M - Seeking Alpha
- 16 days ago - UCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX® (bimekizumab-bkzx) - Benzinga
- 4 weeks ago - United Community Banks Inc (UCB) Announces Upcoming Fourth Quarter 2024 Financial Results Release - GuruFocus
- 2 months ago - United Community Banks to acquire ANB Holdings in an all-stock deal - Seeking Alpha
- 2 months ago - Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside - Benzinga
- 2 months ago - FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease - Benzinga
- 2 months ago - UCB gets FDA approval for Bimzelx for hidradenitis suppurativa - Seeking Alpha